ASAPS: Americans Still Willing to Pay for Good Looks

by jfrentzen 5/14/2009 10:41:00 AM

A panel of aesthetic practitioners talked-up the popularity of facial rejuvenation in a down economy at the recent meeting of the American Society for Aesthetic Plastic Surgery (ASAPS), which was held this month in Las Vegas. What downturn? Americans pay $12 billion to look good:

Americans spent nearly $12 billion on cosmetic procedures last year—much of it on breast implants, surgical facelifts, and Botox injections, but sought out hyaluronic acid injections, fractional resurfacing, and especially nonsurgical options, according to Trevor Born, MD, a plastic surgeon from Toronto and New York City. Results from volumizing agents, or fillers, can be fabulous, he said.

Paul Lorenc, MD, of New York City said cosmetic surgery has become more popular today because it's much easier to perform, there's less downtime for recovery, and it's well-exposed in the media.

"Ultimately, we're doing a better job for our patients with less recovery time," he says. "What we were doing 10 years ago was archaic. We have progressed tremendously in the name of patient benefits and patient safety."

Other factors that might influence someone's decision to pursue nonsurgical procedures include decreased risk of serious complications and the patient's medical history.

The cost of nonsurgical cosmetic treatment is quite a bit less than surgical alternatives, says Barry DiBernardo, MD, FACS, of Montclair, NJ. Expenditures for nonsurgical procedures totaled $4.56 million in 2008, compared with $7.22 million for surgical procedures, the society reported.

The No. 1 surgical procedure nationwide was breast augmentation (355,671). The average cost is $3,885 for silicone gel implants and $3,603 for saline implants. The top nonsurgical procedure was Botox injections (2.46 million), at an average cost of $443 per treatment.

Facelifts are still the main component of cosmetic treatments, with 132,000 procedures performed in 2008 at an average cost of $6,728.

While we're on the subject of the ASAPS meeting, The New York Times offered an interesting closing statement about the state of the plastic surgery field, in its article, Hurt by Economy, Plastic Surgeons Find Hope in New Products:

Doctors at the conference hoped to get out the message that they were far from the stereotypes of predatory practitioners who take advantage of patients’ insecurities. They resent portrayals like that from a “Sex and the City” episode in which Samantha Jones, played by Kim Cattrall, is worried about aging and wants a small operation but is told by a physician that she ought to consider several other procedures. She eventually decides on “aging gracefully.”

Of the fictional surgeon’s behavior, Dr. Robert Singer of San Diego said, “That never happens.” Dr. Singer added: “I generally will turn that question in a different way when a patient asks me what I think she needs done. It’s not a matter of what I say. It’s what bothers you.”

Dr. Singer said that part of the challenge was managing patient expectations.

“The public wants something that has essentially no down time, that has maximum improvement, that is non-invasive, that has no discomfort and that has no cost,” Dr. Singer said. “They want magic. That magic pill doesn’t exist.”

 

Day 3 at the ASAPS Meeting: Over-expansion of Laser Lipolysis?

by jfrentzen 5/5/2009 2:04:00 PM

At a meeting as quiet as this year's ASAPS, attendees are buzzing about the future of laser lipolysis and the expanding range of new technologies that continue to launch from laser system companies. Where is the ceiling for this category? Haven't we seen the saturation of laser lipolysis products in the aesthetic market? Look at the number of players in this space -- Alma, Lumenis, Lutronic, Cool Touch, Candela, Cutera, Cynosure, Eclipse, Palomar, Syneron, Fontana, etc. etc. etc. Consider the consolidation that created Solta, which combined two industry leaders, Reliant and Thermage, under a single corporate logo.

Physicians at ASAPS are voicing a sense of wonder that so many companies can compete successfully in a saturated market, in which new companies often appear (check out the Korean firm Sota, over on the 200 block of the exhibit hall).

One of the new products being introduced at the ASAPS meeting is the Joule laser platform from Sciton. The product is impressive-looking among the modular, one-size-fits-all genre of laser systems. It offers three delivery systems: arm, fiber, or broadband light (BBL) -- the latter term being closely related to Intense Pulsed Light, the nonablative, light-based technology that targets melanin and hemoglobin and stimulates the formation of collagen and elastin.

The Joule offers a wide range of procedures, based on the number of "plug-in" modules one buys. Laser-assisted lipolysis, deep and fractional skin resurfacing, hair removal, a suite of vascular treatments, etc. According to Sciton, the sky is the limit. In addition to any combination of three delivery modes, the base laser system has four laser bays as well as a pulsed light bay.

Modules currently available for the Joule platform:

1. Contour TRL: 2940 nm robotically-scanned MicroLaserPeel or tunable deep skin peeling
2. ProFractional-XC: 2940 nm fractional skin resurfacing with tunable thermal effects
3. ProFractional: 2940 nm for fractional skin resurfacing
4. ClearScan: 1064 nm for hair removal, pigmented and vascular lesions
5. ThermaScan: 1319 nm for non-ablative treatment of fine lines and wrinkles, acne, acne scars
6. BBL: broadband light for pigmented and vascular lesions, hair removal, acne
7. SkinTyte: infrared light for tissue firming, on or off face
8. ProLipo PLUS: 1064 nm and 1319 nm, used individually or in combination for laser-assisted lipolysis
9. Pro-V: 1319 nm for endovenous ablation (EVA) for the treatment of leg veins

The above material is taken directly from Sciton's fact sheet. Incidentally, although press reports claim the Joule platform was officially launched in February, this is the first time I've seen it.

Days 1 and 2 at the ASAPS Meeting: Panel Days

by jfrentzen 5/5/2009 7:04:00 AM

The ASAPS meeting -- that's American Society of Aesthetic Plastic Surgeons -- has taken over one of two exhibit halls at the ornate Mandalay Bay Casino and Resort in sultry Las Vegas. The overcast skies of the week have apparently influenced the feeling at the meeting -- business continues to be down among attendees and exhibitors, but everyone seems to be used to that reality.

My first 2 days at the meeting have been spent hooking-up with physicians and being very PSP-centric: find hot topics that physicians can either write about or report on in upcoming issues of the magazine. So far, and perhaps due to that orientation, I have not encountered much in the way of new technology and products... although I'm assured by my "spies" and correspondents that a lot of good research and work has been going into the hot topics from last year's meetings. Fat transfer, cryolipolysis, new noninvasive methods of doing procedures, and -- in the scientific panel sessions, at any rate -- how to reverse or mediate the effects of bad plastic surgery.

So-called "awful plastic surgery" has become a popular attraction on the Internet, and there are physicians here who want to see more attention paid to how to avoid it. Ford Nahai, MD, led a panel on unnatural outcomes to the face and neck. Specific issues addressed included hallowing of the eyes, the "Lateral Sweep" deformity, unnatural scars and hairlines, and more.

Another panel was titled "Overcoorrection/undercorrection and the Iatrogenic Deformity of the Neck Following Rhytidectomy." (Say that five times really fast.) One of the more interesting panel discussions focused on how surgeons can (and should) reassess their failed breast augmentation results. A panel led by Robert Singer, MD, looked at the root of common complications following aesthetic surgery.

 

Authors

Tags

Powered by BlogEngine.NET 1.3.1.0